| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 135 |
| 1 | ETOPOSIDE | 134 |
| 2 | ATEZOLIZUMAB | 90 |
| 3 | PREDNISONE | 63 |
| 4 | ALBUTEROL SULFATE | 61 |
| 5 | OSIMERTINIB | 59 |
| 6 | ASPIRIN | 58 |
| 7 | ASPIRIN 325 MG | 57 |
| 8 | ASPIRIN 81 MG | 57 |
| 9 | PANTOPRAZOLE | 52 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LURBINECTEDIN | 10 | 0.0086 |
| 1 | AMIFAMPRIDINE PHOSPHATE | 21 | 0.0071 |
| 2 | AFATINIB | 33 | 0.0050 |
| 3 | TOPOTECAN HYDROCHLORIDE | 10 | 0.0041 |
| 4 | BARICITINIB | 12 | 0.0039 |
| 5 | GEFITINIB | 31 | 0.0034 |
| 6 | TOPOTECAN | 14 | 0.0023 |
| 7 | ATEZOLIZUMAB | 90 | 0.0023 |
| 8 | ETOPOSIDE | 134 | 0.0018 |
| 9 | OSIMERTINIB | 59 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 164 |
| 1 | Corticosteroid [EPC] | 158 |
| 2 | Kinase Inhibitor [EPC] | 143 |
| 3 | Topoisomerase Inhibitor [EPC] | 139 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 128 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 95 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 72 |
| 7 | Benzodiazepine [EPC] | 69 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 63 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 60 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 2 | Topoisomerase Inhibitor [EPC] | 139 | 0.0018 |
| 3 | Non-Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 4 | Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 5 | Provitamin D2 Compound [EPC] | 43 | 0.0014 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 128 | 0.0013 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 28 | 0.0013 |
| 8 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 9 | Vasopressin V2 Receptor Antagonist [EPC] | 14 | 0.0009 |